Skip to main content
. 2016 Nov 2;96(2):261–269. doi: 10.1007/s00277-016-2859-8

Fig. 2.

Fig. 2

Survival in patients with monoclonal gammopathy of undetermined significance (MGUS), with and without a personal history of autoimmune disease, compared to controls with and without a personal history of autoimmune disease